New anthra[2,3-b]furancarboxamides: A role of positioning of the carboxamide moiety in antitumor properties-Reference-Cited by-同舟云学术

New anthra[2,3-b]furancarboxamides: A role of positioning of the carboxamide moiety in antitumor properties

Published:2019-03 Issue: Volume:165 Page:31-45
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Volodina Yulia L.,Dezhenkova Lyubov G.,Tikhomirov Alexander S.,Tatarskiy Victor V.,Kaluzhny Dmitry N.,Moisenovich Anastasia M.,Moisenovich Mikhail M.,Isagulieva Alexandra K.,Shtil Alexander A.,Tsvetkov Vladimir B.,Shchekotikhin Andrey E.

Funder

Russian Science Foundation

Ministry of Science and Higher Education

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference59 articles.

1. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity;Minotti;Pharmacol. Rev.,2004

2. Chemistry and Pharmacology of Anticancer Drugs;Thurston,2007

3. Anthracycline chemotherapy and cardiotoxicity;McGowan;Cardiovasc. Drugs Ther.,2017

4. Advances in studies of tyrosine kinase inhibitors and their acquired resistance;Jiao;Mol. Canc.,2018

5. Kinase-targeted cancer therapies: progress, challenges and future directions;Bhullar;Mol. Canc.,2018

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The chemistry of heterocycles in the 21st century;Russian Chemical Reviews;2024-07

2. Thiadiazole-, selenadiazole- and triazole-fused anthraquinones as G-quadruplex targeting anticancer compounds;European Journal of Medicinal Chemistry;2024-03

3. Synthesis and antitumor activity of cyclopentane-fused anthraquinone derivatives;European Journal of Medicinal Chemistry;2024-02

4. Comparative Evaluation of the Antibacterial and Antitumor Activities of 9-Phenylfascaplysin and Its Analogs;Marine Drugs;2024-01-23

5. Synthesis and Biological Evaluation of Chalconesulfonamides: En Route to Proapoptotic Agents with Antiestrogenic Potency;Pharmaceuticals;2023-12-25